Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells-Reference-Cited by-同舟云学术

Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells

Published:2014-11-25 Issue:1 Volume:4 Page:
ISSN:2045-3701
Container-title:Cell & Bioscience
language:en
Short-container-title:Cell Biosci

Author:

He Qingzhong,Zhang Haisong,Wang Youzhao,Ting Hong Hoi,Yu Wenhua,Cao Xuetao,Ge Wei

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://link.springer.com/content/pdf/10.1186/2045-3701-4-70.pdf

Reference25 articles.

1. Karpovsky B, Titus JA, Stephany DA, Segal DM: Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies. J Exp Med. 1984, 160: 1686-1701. 10.1084/jem.160.6.1686

2. Perez P, Hoffman RW, Shaw S, Bluestone JA, Segal DM: Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Nature. 1985, 316: 354-356. 10.1038/316354a0

3. Staerz UD, Kanagawa O, Bevan MJ: Hybrid antibodies can target sites for attack by T cells. Nature. 1985, 314: 628-631. 10.1038/314628a0

4. Staerz UD, Bevan MJ: Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci U S A. 1986, 83: 1453-1457. 10.1073/pnas.83.5.1453

5. Lanzavecchia A, Scheidegger D: The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur J Immunol. 1987, 17: 105-111. 10.1002/eji.1830170118

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid, site-specific labeling of “off-the-shelf” and native serum autoantibodies with T cell–redirecting domains;Science Advances;2022-05-06

2. Rapid Production of Bispecific Antibodies from Off-the-Shelf IgGs with High Yield and Purity;Bioconjugate Chemistry;2021-12-12

3. Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody;Antibody Therapeutics;2021-10

4. IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma;PLOS ONE;2018-04-05

5. CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer;The Journal of Immunology;2017-01-04